Table of Contents Table of Contents
Previous Page  123 / 398 Next Page
Information
Show Menu
Previous Page 123 / 398 Next Page
Page Background

118

Early biopsy with characteristic histologic findings helps the diag-

nosis. Treatment of choice for small, well-circumscribed lesions

is enucleation.

http://dx.doi.org/10.1016/j.ijom.2017.02.413

We can save not only lives, but also quality of life:

submandibular gland-sparing neck dissection

K.C. Chen

∗

, T.Y. Wong, J.S. Huang, T.T. Huang

National Cheng Kung University Hospital, Chinese Taipei

Background:

Saliva is important to oral health and submandibu-

lar gland provide 70% of daily production. Neck dissection with

gland removal is the traditional guideline in oral squamous cell

carcinoma (OSCC) patients. Reduction of saliva would be noted

postoperatively and impairs quality of life (QoL) due to xerosto-

mia. Survival rate of OSCC reaches a plateau and what we can do

more is to improve QoL.

Objectives:

According to some published papers and our own

study. Almost no submandibular glands metastasis by pathology

even in positive level Ib neck. Our idea is that why we don’t try to

preserve submandibular gland since it seems to be safe to keep in

neck.

Methods:

Preserve gland in ipsilateral or contralateral pathologi-

cal N0 neck. Subjective test for function are saliva flow fromorifice

by digital pressure and patient’s sensation. Saliva scintigraphy

worked as objective test.

Findings and Conclusion:

From 2004 to 2016, total 58 cases

included 59 tumours and 63 necks and glands. Fail to complete

functional tests in seven glands finally due to recurrence or radio-

therapy. Four local recurrence and three neck recurrence in average

33 months follow-up. In 56 glands with tests, two cases without

saliva flow from orifice were observed and three cases felt mild

xerostomia. Saliva scintigraphy was done in 24 cases, seven cases

showed normal function, 13 cases showed mild xerostomia. Oth-

ers are moderate xerostomia. We conclude that our method not

only preserve function but also no increasing risk to recurrence.

In other words, we could save not only lives but also QoL.

http://dx.doi.org/10.1016/j.ijom.2017.02.414

Clinical implication of discrepancy between overall survival

and disease-specific survival rate in oral cavity squamous cell

carcinoma

C.S. Cheng

∗

, Y.M. Chang

Department of Stomatology, Division of Oral and Maxillofacial

Surgery, Taichung Veterans General Hospital, Chinese Taipei

Generally, two types of survival estimations, overall survival (OS)

and disease-specific survival (DSS) rate, are commonly used to

measure clinical prognosis and explore predictive factors as well.

OS rate is commonly used by clinicians due to the patients survival

status can be easily obtained but without any information about

underlying causes of death. On the other hand, DSS rate is more

sophisticated that counts death caused by specific disease; other

causes of death were refereed as right-censored. Thus, it could be

easy to find the discrepancy (gap or disparity) between two survival

estimations. However, the most important argument is that this

discrepancy (gap or disparity) could be representing the possibility

to increase the bias (overestimation or/and underestimation).

The aim of this study was to investigate characteristics of this

discrepancy between two survival curves to explore the clinical

implications. We studied consecutive patients with oral cavity

squamous cell carcinoma (1985–2013). In our primarily result

showed, age of 60 years as a cut-off point to show discrepancy

occurred significantly that increased by aged patients. In case of

evaluation of outcomes by overall survival rate, it is significant

amount of non-cancer death as a competitive risk might cause

overestimation of mortality of elder patients. So we recommend

that disease-specific survival rate could be an adequate estimation

for elderly patients, especially over the age of 60 years.

http://dx.doi.org/10.1016/j.ijom.2017.02.415

Induction chemotherapy with or without radical surgery for

advanced stage-IVb oral cancer: seven-year experience of

National Taiwan University Hospital

E.S.J. Cheng

School of Dentistry, National Taiwan University and

Department of Oral and Maxillofacial Surgery, National Taiwan

University Hospital, Taipei, Chinese Taipei

Background:

The strategy of clinical stage-IVb oral cancer is

quite challenging. Especially when it involves the infratemporal

region, the five-year survival rate is dismal and less than 20%.

Objectives:

The purpose of this study was to explore the effect of

induction chemotherapy (IC) and flexibility of proposed infratem-

poral resection method for advanced oral cancer.

Methods:

88 cases completed the full treatment protocol from

98 enrolled patients. 48 group one patients were administered

for two cycles of bevacizumab 100 mg/vial on day one, cisplatin

75 mg/m

2

on day one, fluorouracil 1000 mg/m

2

on day 1, 2 (APF)

followed by radical surgery and concurrent chemoradiotherapy

(CCRT), mainly based on internal carotid artery spared, partial

response (more than 30% tumour shrinkage), systemic considera-

tion or patient’s motivation. The IC regimen and CCRT were only

applied to 40 subjects of group two not eligible for surgery. We

proposed a surgical technique to undergo radical infratemporal

resection with coronal approach to basal skull. The primary end

point was overall survival (OS). Secondary end points comprised

flexibility of proposed surgical method, IC effect and complication

rate.

Findings:

Neither unexpected toxicities nor mortality was docu-

mented during the first two months. No difference of complication

rate was recorded. However, partial response of IC was favoured

by surgical group as 54%. Furthermore, five-year OS had signifi-

cantly shown longer for surgical group than the other (52% versus

22%,

P

< 0.01).

Conclusion:

The study demonstrated the IC combined with pro-

posed surgical technique could be employed for those advanced

stage-IVb oral cancer patients.

http://dx.doi.org/10.1016/j.ijom.2017.02.416